An evaluation of Japan's first safeguards actions

被引:3
|
作者
Kuno, A
机构
[1] Mitsubishi UFJ Research and Consulting, Tokyo
关键词
D O I
10.1111/j.1467-9701.2006.00819.x
中图分类号
F8 [财政、金融];
学科分类号
0202 ;
摘要
Japan has been one of the major GATT/WTO member countries with relatively little experience in implementing protectionist measures. However, in April 2001, for the first time in its history, Japan invoked provisional safeguard measures against imports of Welsh onions, Shiitake mushrooms and Tatami mats mainly from China. This paper reviews and evaluates the chain of events regarding these safeguard actions, and considers the means by which Japan might be able to deal with its 'trilemma' policy problem involving how to coordinate the promotion of trade liberalisation, the administration of WTO-consistent safeguards and responses to domestic political demands for protection. The paper first attempts to review the theoretical rationale for implementing safeguard measures and counterarguments against these measures. Second, it discusses the economic circumstances in which Japan implemented the safeguard measures and evaluates these measures critically from the standpoint of economic efficiency and the political economy interests involved. Finally, it concludes with a recommendation that the aforementioned 'trilemma' policy problem in Japan can be best addressed by means of the introduction of a 'well-institutionalised' domestic programme to provide adjustment assistance to ameliorate the displacement resulting from import surges. © 2006 The Authors Journal compilation © 2006 Blackwell Publishing Ltd.
引用
收藏
页码:763 / 782
页数:20
相关论文
共 50 条
  • [41] Scientific Community Actions to Shape Enhanced Nuclear Safeguards and Non-proliferation Policies
    Mansouri, Reza
    Janssens, Willem
    Rabinovici, Eliezer
    Cotta-Ramusino, Paolo
    INTERNATIONAL COOPERATION FOR ENHANCING NUCLEAR SAFETY, SECURITY, SAFEGUARDS AND NON-PROLIFERATION, 2016, 172 : 77 - 88
  • [42] Analysis of safety-related regulatory actions by Japan's pharmaceutical regulatory agency
    Ishiguro, Chieko
    Misu, Takashi
    Iwasa, Eiko
    Izawa, Tadashi
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 (11) : 1314 - 1320
  • [43] Challenge to improve Japan's deplorable HPV vaccination rate by local government actions
    Miyoshi, Ai
    Ueda, Yutaka
    Yagi, Asami
    Kimura, Toshihiro
    Kobayashi, Eiji
    Tasaka, Keiichi
    Todo, Aiko
    Matsunami, Katsura
    Matsuoka, Taro
    Kimura, Tadashi
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2022, 48 (05) : 1233 - 1239
  • [44] When Actions Match Words: Japan's National Security Strategy at One Year
    Johnstone, Christopher B.
    WASHINGTON QUARTERLY, 2024, 47 (01): : 167 - 183
  • [45] First evaluation of Eyberg Child Behavior Inventory for foster children in Japan
    Matano, Miyuki
    Katabira, Hisayo
    Sekine, Tomoe
    Kurane, Koyuru
    Wakabayashi, Kei
    Kono, Yumi
    Tajima, Toshihiro
    Iwai, Kosuke
    Osaka, Hitoshi
    Monden, Yukifumi
    PEDIATRICS INTERNATIONAL, 2024, 66 (01)
  • [46] Japan's chemical makers enjoy strong first half
    Mccoy, Michael
    CHEMICAL & ENGINEERING NEWS, 2017, 95 (45) : 13 - 13
  • [47] Japan's first BSE case fuels fears elsewhere
    David Cyranoski
    Nature, 2001, 413 : 337 - 337
  • [48] Japan's first BSE case fuels fears elsewhere
    Cyranoski, D
    NATURE, 2001, 413 (6854) : 337 - 337
  • [49] Forced Labour in Imperial Japan's First Colony: Hokkaido
    Jolliffe, Pia M.
    ASIA-PACIFIC JOURNAL-JAPAN FOCUS, 2020, 18 (20):
  • [50] FIRST-IN-HUMAN TRIALS: REGULATOR'S PERSPECTIVE IN JAPAN
    Asakura, W.
    Iguchi, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 51 - 52